efficacy

related words
vaccine
preclinical
commercialized
demonstrate
therapeutic
compound
collaborative
cryoablation
cubicin
study
hematide
safer
investigator
novel
marketed
tm
bidil
gene
investigational
announce
related documents
1446847--3/30/2010--IRONWOOD_PHARMACEUTICALS_INC
919722--3/16/2007--SUPERGEN_INC
919722--3/16/2006--SUPERGEN_INC
1469510--3/30/2010--Resolute_Energy_Corp
1444570--12/17/2010--Axcan_Intermediate_Holdings_Inc.
95052--8/17/2010--ELIZABETH_ARDEN_INC
1178104--9/24/2010--CARDICA_INC
1138723--9/1/2010--ACCURAY_INC
831547--4/5/2010--SPECTRUM_PHARMACEUTICALS_INC
1318310--2/25/2010--ev3_Inc.
875320--2/19/2010--VERTEX_PHARMACEUTICALS_INC_/_MA
1317872--3/11/2010--TomoTherapy_Inc
1360214--3/31/2010--TRANSDEL_PHARMACEUTICALS_INC
1230355--3/12/2010--TRANS1_INC
1183765--3/8/2010--THRESHOLD_PHARMACEUTICALS_INC
1080014--2/26/2010--THERAVANCE_INC
919722--3/15/2010--SUPERGEN_INC
1172480--3/4/2010--SANTARUS_INC
1328003--3/29/2010--Redpoint_Bio_CORP
707511--3/31/2010--REGENERX_BIOPHARMACEUTICALS_INC
related topics
{product, candidate, development}
{product, liability, claim}
{financial, litigation, operation}
{acquisition, growth, future}
{regulation, change, law}
{loan, real, estate}
{gas, price, oil}
{stock, price, operating}
{regulation, government, change}
{operation, international, foreign}
{product, market, service}
{cost, contract, operation}
{cost, regulation, environmental}
{customer, product, revenue}
{interest, director, officer}
{loss, insurance, financial}
{property, intellectual, protect}
{system, service, information}
{provision, law, control}
{control, financial, internal}